Schwartz Norman D Insider Trades

Insider Trading History

Track insider trading activity for Schwartz Norman D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $1.85M 6,010 shares
Last Trade
Sep 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$895k 3,005 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $0 0 shares
Last Trade
Sep 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 1,266 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $136M 441,507 shares
Last Trade
Sep 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$919k 3,084 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $136M 441,507 shares
Last Trade
Sep 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$919k 3,084 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO.B
10% owner, Chairman & CEO
Holding Value $125M 441,507 shares
Last Trade
Sep 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$919k 3,084 shares
$297.88
$283.45
Bio-Rad Laboratories
Bio-Rad Laboratories BIO.B
10% owner, Chairman & CEO
Holding Value $126M 444,591 shares
Last Trade
Sep 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.8M 6,353 shares
$283.45
$283.45
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $0 0 shares
Last Trade
Sep 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 1,266 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $1.85M 6,010 shares
Last Trade
Sep 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$895k 3,005 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $640k 2,082 shares
Last Trade
Sep 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$620k 2,082 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $640k 2,082 shares
Last Trade
Sep 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$620k 2,082 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $137M 444,591 shares
Last Trade
Sep 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.89M 6,353 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $137M 444,591 shares
Last Trade
Sep 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.89M 6,353 shares
$297.88
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO.B
10% owner, Chairman & CEO
Holding Value $3.31M 11,671 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.99M 11,671 shares
$256.45
$283.45
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $3.59M 11,671 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.99M 11,671 shares
$256.45
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman & CEO
Holding Value $4.25M 13,822 shares
Last Trade
Sep 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.56M 13,822 shares
$329.75
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman, President, And CEO
Holding Value $135M 438,238 shares
Last Trade
Sep 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$415k 1,241 shares
$334.31
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman, President, And CEO
Holding Value $135M 439,479 shares
Last Trade
Sep 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$776k 2,320 shares
$334.31
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman, President, And CEO
Holding Value $0 0 shares
Last Trade
Sep 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$776k 2,320 shares
$334.31
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman, President, And CEO
Holding Value $135M 438,124 shares
Last Trade
Sep 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$609k 1,805 shares
$337.32
$307.47
Bio-Rad Laboratories
Bio-Rad Laboratories BIO
10% owner, Chairman, President, And CEO
Holding Value $134M 437,159 shares
Last Trade
Sep 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$326k 965 shares
$337.32
$307.47

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up